F

Fosun Pharma

4119 employees

Fosun Pharma is a pharmaceutical company.

Investor insights

Sectors invested in

Health Care12
Biotechnology10
Pharmaceutical7
Medical6
Medical Device5
Biopharma3
Health Diagnostics2
Therapeutics2
Ophthalmology1
Software1
3D Technology1
mHealth1
E-Commerce1
B2B1
Trading Platform1
Alternative Medicine1
Manufacturing1
Product Research1
Personal Health1
Electronics1

Funding rounds participated in

$17M sweet spot round size

Most of their 31 investments are in rounds between $11M and $31M

Investor type

Venture Capital

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

1994

Investments made

S

Scolioscan - Telefield Medical Imaging Limited raised $5.1M on May 18, 2023

Investors: Hong Kong Polytechnic University and Fosun Pharma

U

Undisclosed raised $76M on August 19, 2022

Investors: 惠每资本, China Merchants Capital, China Merchants Securities Co., Ltd., 华泰紫金投资有限责任公司, Hillhouse Capital Management and Fosun Pharma

U

Undisclosed raised $15M on August 2, 2022

Investors: Fosun Pharma

Z

ZuriMED Technologies AG raised $7.1M on July 4, 2022

Investors: Fosun Pharma

U

Undisclosed raised $31M on March 14, 2022

Investors: 泰福资本 TF Capital, Kunlun Capital Pte. Ltd., 江苏瑞华投资控股集团有限公司, CDH Investments, 夏尔巴股权投资管理有限公司 and Fosun Pharma

U

Undisclosed raised $31M on March 14, 2022

Investors: 泰福资本 TF Capital, Hillhouse Capital Management, 夏尔巴股权投资管理有限公司, CDH Investments, Beijing Kunlun Tech Co Ltd (SZ:300418) and Fosun Pharma

I

Insilico Medicine raised undisclosed on January 11, 2022

Investors: Fosun Pharma

U

Undisclosed raised undisclosed on May 20, 2021

Investors: SoftBank China Capital, Hillhouse Capital Management, LYFE Capital and Fosun Pharma

G

Gyroscope Therapeutics raised $149M on March 26, 2021

Investors: Tetragon Financial Group Limited, Forbion, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Cambridge Innovation Capital plc, Syncona Limited and Fosun Pharma

M

MitrAssist raised $50M on December 3, 2020

Investors: 6 Dimensions Capital, CITIC Capital, Centurium Capital and Fosun Pharma

FAQ